Drug development through the formal clinical trials process is slow and expensive. Real World Evidence (RWE) drug development is fast and cheap. Have we got your attention yet?
Psychedelics
COMPASS Pathways is granted new US patent for crystalline psilocybin
Compass Pathway's fourth U.S. patent covers its Form A hydrate psilocybin, and is the first patent for this formulation.
Levitee Labs Announces Agreement with Adracare, a WELL Health Company, to Support Individuals with Addiction and Mental Health Conditions
Levitee Labs announces a partnership with Adracare Inc., a subsidiary of Well Health Technologies (WELL), to build out a digital therapeutics platform.
Oakland Psychedelics Activists Launch Initiative To Legalize Community-Based Sales With Support From City Council
Oakland activists are hoping to expand upon the city’s current psychedelics decriminalization ordinance by creating a community-based model through which people could legally purchase entheogenic substances from local producers.
Singer Melissa Etheridge And Activist Van Jones Promote Psychedelics Reform As Movement Grows
The fight to end the criminalization of psychedelics and give patients access to natural plants and fungi has achieved success in a growing number of cities and states in recent years, and on Thursday the cause got a boost from prominent people in the entertainment and political fields.
Psychedelic Medicine: The Only Hope In Solving The Mental Health LABOR CRISIS
The "crippling labor shortages" plaguing the U.S. economy are directly attributable to the Mental Health Crisis. Psychedelic medicine is the only answer.
Novamind Granted DEA Licenses for Psilocybin Research
Novamind's new DEA licenses open up opportunities to host formal clinical trials.
PharmaTher Granted FDA Orphan Drug Designation For Ketamine To Treat Complex Regional Pain Syndrome
PharmaTher receives its second FDA orphan drug designation for a ketamine-based therapy.
MindMed Joins Clinical Trials Transformation Initiative
MindMed joins the Clinical Trials Transformation Initiative, a forward-looking healthcare association that develops/promotes new health therapies.
Denver City Panel Pushes To Expand Psilocybin Decriminalization With Gifting And Communal Use
Denver activists, police officials and other experts have agreed upon a set of recommendations to expand the city’s historic vote to decriminalize psilocybin in 2019—including by deprioritizing criminal enforcement against additional activities like gifting and communal use of the fungi.
Cybin Files an International Patent Application Covering Psychedelic Delivery Methods
Cybin files a new patent application in support of the development of drug candidate CYB004.
Psychedelic Stocks: Financial Strength, Growth Potential, Compelling Valuations
Psychedelic stocks today are cash-rich with extremely attractive valuations. Blue-chip stocks sit with record debt levels and grossly inflated valuations. Advantage: psychedelic stocks.
GOP Pennsylvania Lawmaker Files Psilocybin Research Bill For Veterans And First Responders
A coalition of Pennsylvania lawmakers introduced a bill this week that’s meant to promote research into the therapeutic potential of psilocybin mushrooms for mental health conditions such as post-traumatic stress disorder —the latest example of how the psychedelics reform movement is gaining momentum.
Numinus Upgrades Psychedelics Lab to Increase Research Service Capabilities
Numinus announces expansion of its psychedelics research facility and an application to Health Canada for a second Dealer's License.
Novamind Launches New Psychedelic Palliative Care Program
Novamind is expanding its mental health care to include the treatment of patients with palliative needs, via its new Murray, Utah treatment clinic.